Atea Pharmaceuticals Inc.

NASDAQ: AVIR · Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Atea Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-136.13M -139.49M -168.38M -174.01M -176M -163.66M -135.96M -131.22M -106.15M -109.3M -115.91M 35.65M 15.53M 48.4M 121.19M 24.71M 35.29M 23.75M
Depreciation & Amortization
416K 416K 416K 416K 416K 416K 416K 416K 418K 357K 260K 163K 64K 29K 29K 28K 26K 22K
Stock-Based Compensation
38.08M 46.13M 51.77M 49.63M 49.85M 49.48M 49.43M 48.92M 48.04M 47.59M 46.72M 46.42M 45.91M 44.01M 39.62M 31.09M 24.34M 14.54M
Other Working Capital
-14.24M -9.43M -7.68M 5.09M 17.91M 13.76M 14.46M 7.09M -8.89M -18.95M -44.6M -229.05M -195.7M -227.31M -258.13M -300.34M -325.8M -284.99M
Other Non-Cash Items
-8.37M -10.07M -11.82M -4.95M 30.79M 62M 62.4M 55.24M 6.86M -21.34M -18.23M -263.08M -248.33M -251.01M -247.48M 300.57M 302.11M 307.6M
Deferred Income Tax
n/a n/a n/a -8.51M -45.97M -77.85M -77.85M -69.34M -31.88M n/a n/a 247.84M 247.84M 247.84M 247.84M -300.2M -300.2M -300.2M
Change in Working Capital
-10.86M -23.18M -7.48M 10.48M 19.42M 34.2M 16.16M 10.89M -18.82M -21.91M -46.59M -254.64M -192.51M -221.63M -247.84M 251.11M 215.2M 246.09M
Operating Cash Flow
-116.86M -126.2M -135.5M -126.94M -121.49M -95.41M -85.39M -85.11M -88.76M -91.82M -120.98M -174.86M -131.01M -129.18M -87M 306.94M 274.86M 284.4M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a 1.94M 1.92M 44K n/a -1.95M -1.93M -48K -4K -5K -20K -26K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-510.08M -416.62M -461.18M -449.93M -426.98M -572.93M -562.36M -573.53M -368.24M -215.02M -58.4M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
485.6M 501.53M 517.28M 537.18M 577.72M 645.56M 602.66M 619.55M 472.77M 272.99M 91.89M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 46.56K 71.05K -1.87M -488.83M -488.87M -488.9M -486.96M -4K -4K -4K -26K -26K -26K
Investing Cash Flow
-24.48M 84.91M 56.1M 87.25M 150.75M 72.63M 40.3M 46.02M -382.44M -430.89M -455.41M -488.9M -1.93M -48K -4K -5K -20K -26K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-14.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
138K 138K n/a n/a n/a n/a 165K -65K 82K 82K 140K 512K 1.16M 1.22M 1.47M 320.06M 318.35M 424.74M
Financial Cash Flow
-14.32M -230K 267K 267K 242K 242K 257K 257K 312K 312K 370K 512K 1.16M 1.22M 1.47M 427.54M 425.83M 532.23M
Net Cash Flow
-155.67M -41.52M -79.13M -39.42M 29.5M -22.54M -44.84M -38.83M -470.89M -522.4M -576.02M -663.25M -131.78M -128.01M -85.54M 734.48M 700.67M 816.6M
Free Cash Flow
-116.86M -126.2M -135.5M -126.94M -121.49M -95.41M -85.39M -83.16M -86.83M -91.78M -120.98M -176.81M -132.94M -129.22M -87.01M 306.93M 274.83M 284.38M